Comprehending the proteomic landscape of ovarian cancer: A road to the discovery of disease biomarkers

Shuvolina Mukherjee, Karin Sundfeldt, Carl A.K. Borrebaeck, Magnus E. Jakobsson

Research output: Contribution to journalReview articlepeer-review


Despite recent technological advancements allowing the characterization of cancers at a molecular level along with biomarkers for cancer diagnosis, the management of ovarian cancers (OC) remains challenging. Proteins assume functions encoded by the genome and the complete set of proteins, termed the proteome, reflects the health state. Comprehending the circulatory proteomic profiles for OC subtypes, therefore, has the potential to reveal biomarkers with clinical utility concerning early diagnosis or to predict response to specific therapies. Furthermore, characterization of the proteomic landscape of tumor-derived tissue, cell lines, and PDX models has led to the molecular stratification of patient groups, with implications for personalized therapy and management of drug resistance. Here, we review single and multiple marker panels that have been identified through proteomic investigations of patient sera, effusions, and other biospecimens. We discuss their clinical utility and implementation into clinical practice.

Original languageEnglish
Article number25
Issue number2
Publication statusPublished - 2021

Subject classification (UKÄ)

  • Cancer and Oncology

Free keywords

  • Biomarkers
  • Ovarian cancer
  • Proteomics


Dive into the research topics of 'Comprehending the proteomic landscape of ovarian cancer: A road to the discovery of disease biomarkers'. Together they form a unique fingerprint.

Cite this